
    
      This study is carried out in healthy children aged 6 to 23 months at a single site. A total
      of 285 participants are enrolled, 114, 114 and 57 participants are randomized to either the
      single dose, two-dose Vi-DT regimens or placebo/comparator group, respectively within age
      strata. Three age strata is 6 to less than 9 months, 9 to 12 months and 13 to 23 months. The
      investigators allow the 9-12 months old children to receive Measles-Mumps-Rubella (MMR)
      vaccine concomitantly with Vi-DT vaccine and descriptive analysis of immune response to MMR
      only and to MMR and Vi-DT vaccines are performed to assess the possible immunological
      interference with MMR vaccine.
    
  